• Profile
Close
Sign Up / Log In
Journal Summaries
Endocrinology
  Pharmacology/kinetics

Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial

Diabetes, Obesity and Metabolism | Apr 25, 2020 Pharmacology/kinetics

Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicenter, active‐controlled, randomized, double‐blind study with open‐label extension (EVERGREEN study)

Diabetes, Obesity and Metabolism | Apr 25, 2020 Pharmacology/kinetics

Comorbid conditions and GFR predict nonvertebral fractures in patients with diabetes in an ethnic-specific manner

Journal of Clinical Endocrinology & Metabolism | Apr 13, 2020 Pharmacology/kinetics

Effects of mineralocorticoid and AT1 receptor antagonism on the aldosterone-renin ratio in primary aldosteronism—The EMIRA Study

Journal of Clinical Endocrinology & Metabolism | Apr 13, 2020 Pharmacology/kinetics

Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of five randomized controlled trials

Diabetes Research and Clinical Practice | Apr 10, 2020 Pharmacology/kinetics

Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study

Diabetes, Obesity and Metabolism | Apr 10, 2020 Pharmacology/kinetics

Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9‐39) for treatment of post‐bariatric hypoglycemia

Diabetes, Obesity and Metabolism | Apr 10, 2020 Pharmacology/kinetics

Dapagliflozin vs placebo on left ventricular remodeling in patients with diabetes and heart failure: The REFORM Trial

Diabetes Care | Apr 08, 2020 Pharmacology/kinetics

Safety of dapagliflozin in a broad population of patients with type 2 diabetes – Analyses from the DECLARE – TIMI 58 study

Diabetes, Obesity and Metabolism | Apr 08, 2020 Pharmacology/kinetics

Differential glycaemic control with basal insulin glargine 300 U/mL vs degludec 100 U/mL according to kidney function in type 2 diabetes – A subanalysis from the BRIGHT trial

Diabetes, Obesity and Metabolism | Apr 08, 2020 Pharmacology/kinetics

1 … 27 29 31 … 122
Most read this week
1

Alternative Therapies and Infection Management
Placeholder
2

'Weekend Warrior' Trend: Health Perks for Busy Physicians
Placeholder
3

The Role of Nutrition in Enhancing Fertility for Men and Women
Placeholder
4

Effect of Collagen Vascular Diseases on Eyes: MCQ Challenge
Placeholder
5

More Women Experience Chronic Pain Than Men: Find Out Why
Placeholder
Bannerimg

A variety of information related to Medicine and Health Care. It's all here.

Select Topic

x
M3 app logo
Choose easy access to M3 India from your mobile!

Add to home

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay